These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1933140

  • 1. The effects of naloxone on the cardiovascular and respiratory effects of centrally administered corticotrophin releasing factor in conscious rabbits.
    May CN, Whitehead CJ, Mathias CJ.
    Br J Pharmacol; 1991 Jul; 103(3):1776-80. PubMed ID: 1933140
    [Abstract] [Full Text] [Related]

  • 2. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution.
    May CN, Dashwood MR, Whitehead CJ, Mathias CJ.
    Br J Pharmacol; 1989 Nov; 98(3):903-13. PubMed ID: 2556206
    [Abstract] [Full Text] [Related]

  • 3. The pressor response to central administration of beta-endorphin results from a centrally mediated increase in noradrenaline release and adrenaline secretion.
    May CN, Whitehead CJ, Mathias CJ.
    Br J Pharmacol; 1991 Mar; 102(3):639-44. PubMed ID: 1364832
    [Abstract] [Full Text] [Related]

  • 4. Pressor, tachycardic and behavioral excitatory responses in conscious rats following ICV administration of ACTH and CRF are blocked by naloxone pretreatment.
    Saunders WS, Thornhill JA.
    Peptides; 1986 Mar; 7(4):597-601. PubMed ID: 3020526
    [Abstract] [Full Text] [Related]

  • 5. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M, Kashtanov SI, Fodor M, de Wied D.
    Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
    [Abstract] [Full Text] [Related]

  • 6. Investigation of the central sites at which morphine acts to cause hypertension in conscious rabbits.
    May CN, Whitehead CJ, Dashwood MR, Mathias CJ.
    Br J Pharmacol; 1989 Jul; 97(3):873-81. PubMed ID: 2569348
    [Abstract] [Full Text] [Related]

  • 7. Autonomic and cardiovascular effects of corticotropin-releasing factor in the spontaneously hypertensive rat.
    Brown MR, Hauger R, Fisher LA.
    Brain Res; 1988 Feb 16; 441(1-2):33-40. PubMed ID: 2834002
    [Abstract] [Full Text] [Related]

  • 8. Central nervous system effects of corticotropin releasing factor in the dog.
    Brown MR, Fisher LA.
    Brain Res; 1983 Nov 28; 280(1):75-9. PubMed ID: 6606481
    [Abstract] [Full Text] [Related]

  • 9. [Effects of ketanserin on hemodynamic changes after intracerebroventricular corticotropin releasing factor administration in rats].
    Satoh K, Kushiro T, Kajiwara N.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):303-9. PubMed ID: 3261263
    [Abstract] [Full Text] [Related]

  • 10. Plasma cortisol and catecholamine responses to intracerebroventricular administration of CRF to rhesus monkeys.
    Insel TR, Aloi JA, Goldstein D, Wood JH, Jimerson DC.
    Life Sci; 1984 May 07; 34(19):1873-8. PubMed ID: 6610811
    [Abstract] [Full Text] [Related]

  • 11. CRF initiates biological actions within the brain that are observed in response to stress.
    Lenz HJ, Raedler A, Greten H, Brown MR.
    Am J Physiol; 1987 Jan 07; 252(1 Pt 2):R34-9. PubMed ID: 3544874
    [Abstract] [Full Text] [Related]

  • 12. Effects of mu-opioid receptor agonists on circulatory responses to simulated haemorrhage in conscious rabbits.
    Evans RG, Ludbrook J.
    Br J Pharmacol; 1990 Jul 07; 100(3):421-6. PubMed ID: 2167731
    [Abstract] [Full Text] [Related]

  • 13. Effects of corticotropin-releasing factor on central respiratory activity.
    Böhmer G, Schmid K, Ramsbott M.
    Eur J Pharmacol; 1990 Jul 17; 182(3):405-11. PubMed ID: 2226617
    [Abstract] [Full Text] [Related]

  • 14. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ, Fisher LA, Vale WW, Brown MR.
    Am J Physiol; 1985 Jul 17; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep.
    Weisinger RS, Blair-West JR, Burns P, Denton DA, Purcell B, Vale W, Rivier J, Weisinger HS, May CN.
    Endocrinology; 2004 Dec 17; 145(12):5598-604. PubMed ID: 15319360
    [Abstract] [Full Text] [Related]

  • 16. Intracerebroventricular injection of stresscopin-related peptide enhances cardiovascular function in conscious rats.
    Jin R, Li MZ, Bing YH, Piao RL, Li YJ, Jin QH, Qiu DL, Kannan H, Chu CP.
    Regul Pept; 2013 Sep 10; 186():7-11. PubMed ID: 23850799
    [Abstract] [Full Text] [Related]

  • 17. Corticotropin-releasing factor and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function.
    Fisher LA, Brown MR.
    Brain Res; 1984 Mar 26; 296(1):41-7. PubMed ID: 6608972
    [Abstract] [Full Text] [Related]

  • 18. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
    Diamant M, de Wied D.
    Neuroendocrinology; 1993 Jun 26; 57(6):1071-81. PubMed ID: 8232765
    [Abstract] [Full Text] [Related]

  • 19. Effect of ICV infusion of CRF on blood pressure and adrenal steroids in rabbits.
    Tarjan E, Ferraro T, May CN.
    Neuropeptides; 1995 Jun 26; 28(6):325-31. PubMed ID: 7666951
    [Abstract] [Full Text] [Related]

  • 20. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats.
    Overton JM, Fisher LA.
    J Auton Nerv Syst; 1991 Jul 26; 35(1):43-51. PubMed ID: 1940026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.